Super-Resolution Imaging Uncovers Nanoscale Tau Aggregate Hyperphosphorylation Patterns in Human Alzheimers Disease Brain Tissue
Adriana N. Santiago-RuiziD, Siewert HugelieriD, Gabriela L. Correa, Charles BondiD, Edward B. LeeiD, Melike LakadamyaliiD
Abstract
Tau aggregation plays a critical role in Alzheimers Disease (AD), where tau neurofibrillary tangles (NFTs) are a key pathological hallmark. While much attention has been given to NFTs, emerging evidence underscores nano-sized pre-NFT tau aggregates as potentially toxic entities in AD. By leveraging DNA-PAINT super-resolution microscopy, we visualized and quantified nanoscale tau aggregates (nano-aggregates) in human postmortem brain tissues from intermediate and advanced AD, and Primary Age-Related Tauopathy (PART). Nano-aggregates were predominant across cases, with AD exhibiting a higher burden compared to PART. Hyperphosphorylated tau residues (p-T231, p-T181, and p-S202/T205) were present within nano-aggregates across all AD Braak stages and PART. Moreover, nano-aggregates displayed morphological differences between PART and AD, and exhibited distinct hyperphosphorylation patterns in advanced AD. These findings suggest that changes in nano-aggregate morphology and hyperphosphorylation patterns may exacerbate tau aggregation and AD progression. The ability to detect and profile nanoscale tau aggregates in human brain tissue opens new avenues for studying the molecular underpinnings of tauopathies.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 3
- FWCI
- 0.91
- Field percentile
- top 27%
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Characterization and super-resolution imaging of small tau aggregates in human samples.
D. Boken, D. Cox, … D. Klenerman·bioRxiv·Jun 12, 2023
- A post-translational modification signature defines changes in soluble tau correlating with oligomerization in early stage Alzheimer’s disease brain
Ebru Ercan-Herbst, Jens Ehrig, … Dagmar E. Ehrnhoefer·Acta Neuropathologica CommunicationsPeer-reviewed·Dec 1, 2019
- Nuclear and cellular, micro and nano calcification in Alzheimer's disease patients and correlation to phosphorylated Tau.
E. Tsolaki, L. Csincsik, … S. Bertazzo·bioRxiv·Jun 15, 2020
- The role of positively charged small biomolecules in the aggregation of hyperphosphorylated tau in Alzheimer's disease
- Small tau aggregates exhibit disease-specific molecular profiles across tauopathies
Dorothea Böken, Melissa Huang, … David Klenerman·Cell ReportsPeer-reviewed·Feb 1, 2026
- Phosphorylated tau fluid biomarker sites recognize earlier neurofibrillary tangle maturity levels in the postmortem Alzheimer's disease brain
Christina M. Moloney, Sydney A. Labuzan, … Melissa Erin Murray·Alzheimer s & DementiaPeer-reviewed·Aug 3, 2022